Thoracic and abdominal aortic aneurysms.
Eric M Isselbacher
https://pubmed.ncbi.nlm.nih.gov/15710776Actively Recruiting
Led by Laval University · Updated on 2025-06-29
30
Participants Needed
2
Research Sites
26 weeks
Total Duration
Researchers are studying the effects of a supervised exercise program on patients with non-surgical ascending thoracic aortic aneurysm (ATAA). The study aims to understand how exercise impacts blood pressure, muscle strength, aerobic capacity, and aneurysm size. This prospective, randomized study compares these outcomes in an exercise group versus a control group, addressing the unknown influence of physical activity on aneurysm progression and blood pressure in this population. Participants in the exercise group will follow a 24-week supervised program involving high-intensity interval training on a cycle ergometer and strength training three times per week. Sessions last about 60 minutes, with blood pressure and heart rate monitored throughout. The control group continues usual daily activities and receives consultations with a kinesiologist at baseline, 3 months, and 6 months for lifestyle advice. Both groups undergo measurements and tests at baseline, 3 months, and 6 months. Participants will have various assessments including blood pressure monitoring over 24 hours, cardiopulmonary exercise tests to measure aerobic capacity (VO2max), muscle strength evaluations, body composition analysis, and CT scans to monitor aneurysm size. Physical activity will be tracked using a wearable armband. The primary outcome is aneurysm diameter at 3 months. Safety and progression are closely monitored over the study period, which lasts at least 6 months from the start of intervention.
CONDITIONS
Effects of Exercise on Thoracic Aneurysms
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 24 weeks
Participants in the exercise group follow a 24-week structured supervised exercise program including high intensity interval training and strength training, with personalized adjustments by a certified kinesiologist. Blood pressure and heart rate are monitored during each session.
Approximately 72 exercise sessions (3 times per week)
Duration - 6 months
Participants in the control group continue daily life activities and have consultations with a kinesiologist at baseline, 3 months, and 6 months to receive advice on physical activity and healthy lifestyle.
3 consultations (in-person)
Duration - 6 months
Participants undergo multiple assessments including anthropometric measures, 24-hour ambulatory blood pressure monitoring, cardiopulmonary exercise tests, strength evaluations, and energy expenditure monitoring at baseline, 3 months, and 6 months. CT scans are performed before the study and at 6 months to monitor aneurysm size.
Assessments at baseline, 3 months, and 6 months
Total: 2 locations
1
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Québec, Quebec, Canada, G1V 4G5
Actively Recruiting
2
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Québec, Quebec, Canada, G1V4G5
Not Yet Recruiting
P
Paul Poirier, MD
A
Audrey Auclair, PhD
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Eric M Isselbacher
https://pubmed.ncbi.nlm.nih.gov/15710776Raphael Santos Teodoro de Carvalho, Cássio Mascarenhas Robert Pires, Gustavo Cardoso Junqueira...
https://pubmed.ncbi.nlm.nih.gov/25517389Jeff M Reynolds, Toryanno J Gordon, Robert A Robergs
https://pubmed.ncbi.nlm.nih.gov/16937972Atsuko Nakayama, Hiroyuki Morita, Masatoshi Nagayama...
https://pubmed.ncbi.nlm.nih.gov/29487112